Skip to content

Propofol versus Ketofol in Endoscopic retrograde cholangiopancreatography ERCP BIS guided sedation

Propofol versus Ketofol in Endoscopic retrograde cholangiopancreatography ERCP BIS guided sedation

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR201907799024111
Enrollment
80
Registered
2019-07-05
Start date
2018-02-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

propofol group
ketofol group

Sponsors

National liver institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Adult patients aged 18 to 60 years undergoing ERCP • American Society of Anesthesiologists physical status class I-II.

Exclusion criteria

Exclusion criteria: • Patients with severe cardiovascular disease. • History of bronchial asthma. • Drug allergy to propofol or ketamine. • History of long term uptake of narcotics, benzodiazepine or any neuropsychiatric medication. • Pregnancy. • Obese patient with body mass index more than 36. • History of any neurological insult.

Design outcomes

Primary

MeasureTime frame
•Primary aim of the study was to compare propofol and ketofol as a sedative agent regards induction time and recovery time in adult patients undergoing ERCP.

Secondary

MeasureTime frame
• Secondary aim was to investigate the safety and efficacy of both drugs as regards haemodynamic, respiratory compromise, pain, nausea, vomiting, any psychomimetic effect (Agitation, Irritability…) post procedure patient and endoscopiest satisfaction as well as the total dose of drug consumption.

Countries

Egypt

Contacts

Public ContactHESHAM MAGED

MD

heshammaged@yahoo.com002701223548537

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026